This article was supported through an
unrestricted grant from Sanofi Pasteur.

Annual influenza vaccination is important for the entire population, except those with an absolute contraindication (e.g. allergy to a component in the vaccine, infants under 6 months).1

Learning objectives

After reading this article, pharmacists should be able to:

  • Identify differences between standard and high-dose influenza vaccines
  • Explain the place in therapy of high-dose influenza vaccine
  • Discuss the role of the pharmacist in advising patients about vaccinating against influenza.

Competencies (2016) addressed: 1.1, 1.3, 1.6, 2.1, 3.1

Secondary complications arising from influenza infections include worsening cardiovascular conditions, respiratory conditions, pneumonia, increased hospitalisation and death.1

The Australian Government provides subsidised immunisation through the National Immunisation Program (NIP) for at-risk groups (Table 1). The rest of the population is administered immunisation via their pharmacist, nurse or general practitioner.

Pharmacists play an increasing role in immunisation. Pharmacies offer convenient access for patients. Vaccination services offered, help protect against productivity loss2,3 and contribute to herd immunity.

Test your knowledge on this article’s assessment questions here to earn up to 1.5 Group 2 CPD credits.